Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Start date:
Apr 14, 2021
End date:
Apr 16, 2021
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.
Radcliffe Cardiology is delighted to announce that Transcatheter Interventions Online (TIO) will return for 2021 on April 14-16th, led by course director, Prof Nicolas van Mieghem from Erasmus MC, Rotterdam, NL.
TIO is a free virtual event that brings together…
View more
Author(s):
Christian Spies
,
Ziyad M Hijazi
Added:
3 years ago
Unlike the left-sided semi-lunar valve, clinically significant acquired pulmonary valve disease is rare. However, stenotic or regurgitant pulmonary valve lesions are not uncommon following surgery for congenital heart defects, including tetralogy of Fallot, pulmonary atresia and other surgical procedures requiring reconstruction of the right ventricular outflow tract (RVOT).1–4 Even with the use…
View more
Start date:
Mar 26, 2024
End date:
Mar 28, 2024
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.
Overview
Radcliffe Cardiologyis delighted to announce thatTranscatheter Interventions Online (TIO)will return for 2024 on26-28 March 2024, led by the course director,Prof Nicolas Van Mieghemfrom Erasmus MC, Rotterdam, NL.
TIO brings together leading international faculty to create a rich,…
View more
Author(s):
Hellmuth Weich
Added:
3 years ago
There has been a recent explosion in the field of transcatheter aortic and pulmonary valve replacements, but the atrio-ventricular valves have lagged behind for various reasons with the tricuspid valve undoubtedly the least treated valve of the four. Despite the fact that tricuspid regurgitation (TR) can result in significant symptoms, patients are rarely referred for isolated surgical tricuspid…
View more
Start date:
Mar 15, 2023
End date:
Mar 17, 2023
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.
Overview
Radcliffe Cardiologyis delighted to announce thatTranscatheter Interventions Online (TIO)will return for 2023 on15 – 17 March 2023, led by the course director,Prof Nicolas Van Mieghemfrom Erasmus MC, Rotterdam, NL.
TIO brings together leading international faculty to create a…
View more
Author(s):
Nicolas M Van Mieghem
,
Azeem Latib
,
Kendra J Grubb
,
et al
Start date:
Mar 15, 2023
TIO 2024 - On Demand
Video Series
Author(s):
Raquel del Valle-Fernández
,
Carlos E Ruiz
Added:
3 years ago
Mitral regurgitation (MR) is the second most prevalent valvular heart disease in developed countries and nearly one-third of the patients with isolated, native valve disease are diagnosed with significant MR, according to the Euro Heart Survey on Valvular Heart Disease.1
Mitral valve (MV) complex is a very complicated structure which consists of the mitral annulus (MA), valve leaflets, papillary…
View more